Advertisement
ResearchIn-Press PreviewImmunologyInfectious disease Free access | 10.1172/JCI145516
1Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, United States of America
2Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States of America
3Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, United States of America
4Department of Chemical and Biomolecular Engineering, Johns Hopkins Univeristy, Baltimore, United States of America
5Department of Molecular Microbiology and Immunology, Johns Hopkins University, Baltimore, United States of America
Find articles by
Ogega, C.
in:
JCI
|
PubMed
|
Google Scholar
|
1Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, United States of America
2Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States of America
3Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, United States of America
4Department of Chemical and Biomolecular Engineering, Johns Hopkins Univeristy, Baltimore, United States of America
5Department of Molecular Microbiology and Immunology, Johns Hopkins University, Baltimore, United States of America
Find articles by
Skinner, N.
in:
JCI
|
PubMed
|
Google Scholar
|
1Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, United States of America
2Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States of America
3Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, United States of America
4Department of Chemical and Biomolecular Engineering, Johns Hopkins Univeristy, Baltimore, United States of America
5Department of Molecular Microbiology and Immunology, Johns Hopkins University, Baltimore, United States of America
Find articles by Blair, P. in: JCI | PubMed | Google Scholar
1Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, United States of America
2Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States of America
3Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, United States of America
4Department of Chemical and Biomolecular Engineering, Johns Hopkins Univeristy, Baltimore, United States of America
5Department of Molecular Microbiology and Immunology, Johns Hopkins University, Baltimore, United States of America
Find articles by Park, H. in: JCI | PubMed | Google Scholar
1Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, United States of America
2Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States of America
3Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, United States of America
4Department of Chemical and Biomolecular Engineering, Johns Hopkins Univeristy, Baltimore, United States of America
5Department of Molecular Microbiology and Immunology, Johns Hopkins University, Baltimore, United States of America
Find articles by
Littlefield, K.
in:
JCI
|
PubMed
|
Google Scholar
|
1Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, United States of America
2Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States of America
3Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, United States of America
4Department of Chemical and Biomolecular Engineering, Johns Hopkins Univeristy, Baltimore, United States of America
5Department of Molecular Microbiology and Immunology, Johns Hopkins University, Baltimore, United States of America
Find articles by Ganesan, A. in: JCI | PubMed | Google Scholar
1Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, United States of America
2Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States of America
3Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, United States of America
4Department of Chemical and Biomolecular Engineering, Johns Hopkins Univeristy, Baltimore, United States of America
5Department of Molecular Microbiology and Immunology, Johns Hopkins University, Baltimore, United States of America
Find articles by
Dhakal, S.
in:
JCI
|
PubMed
|
Google Scholar
|
1Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, United States of America
2Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States of America
3Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, United States of America
4Department of Chemical and Biomolecular Engineering, Johns Hopkins Univeristy, Baltimore, United States of America
5Department of Molecular Microbiology and Immunology, Johns Hopkins University, Baltimore, United States of America
Find articles by Ladiwala, P. in: JCI | PubMed | Google Scholar
1Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, United States of America
2Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States of America
3Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, United States of America
4Department of Chemical and Biomolecular Engineering, Johns Hopkins Univeristy, Baltimore, United States of America
5Department of Molecular Microbiology and Immunology, Johns Hopkins University, Baltimore, United States of America
Find articles by Antar, A. in: JCI | PubMed | Google Scholar
1Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, United States of America
2Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States of America
3Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, United States of America
4Department of Chemical and Biomolecular Engineering, Johns Hopkins Univeristy, Baltimore, United States of America
5Department of Molecular Microbiology and Immunology, Johns Hopkins University, Baltimore, United States of America
Find articles by
Ray, S.
in:
JCI
|
PubMed
|
Google Scholar
|
1Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, United States of America
2Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States of America
3Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, United States of America
4Department of Chemical and Biomolecular Engineering, Johns Hopkins Univeristy, Baltimore, United States of America
5Department of Molecular Microbiology and Immunology, Johns Hopkins University, Baltimore, United States of America
Find articles by Betenbaugh, M. in: JCI | PubMed | Google Scholar
1Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, United States of America
2Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States of America
3Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, United States of America
4Department of Chemical and Biomolecular Engineering, Johns Hopkins Univeristy, Baltimore, United States of America
5Department of Molecular Microbiology and Immunology, Johns Hopkins University, Baltimore, United States of America
Find articles by
Pekosz, A.
in:
JCI
|
PubMed
|
Google Scholar
|
1Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, United States of America
2Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States of America
3Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, United States of America
4Department of Chemical and Biomolecular Engineering, Johns Hopkins Univeristy, Baltimore, United States of America
5Department of Molecular Microbiology and Immunology, Johns Hopkins University, Baltimore, United States of America
Find articles by
Klein, S.
in:
JCI
|
PubMed
|
Google Scholar
|
1Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, United States of America
2Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States of America
3Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, United States of America
4Department of Chemical and Biomolecular Engineering, Johns Hopkins Univeristy, Baltimore, United States of America
5Department of Molecular Microbiology and Immunology, Johns Hopkins University, Baltimore, United States of America
Find articles by
Manabe, Y.
in:
JCI
|
PubMed
|
Google Scholar
|
1Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, United States of America
2Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States of America
3Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, United States of America
4Department of Chemical and Biomolecular Engineering, Johns Hopkins Univeristy, Baltimore, United States of America
5Department of Molecular Microbiology and Immunology, Johns Hopkins University, Baltimore, United States of America
Find articles by
Cox, A.
in:
JCI
|
PubMed
|
Google Scholar
|
1Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, United States of America
2Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States of America
3Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, United States of America
4Department of Chemical and Biomolecular Engineering, Johns Hopkins Univeristy, Baltimore, United States of America
5Department of Molecular Microbiology and Immunology, Johns Hopkins University, Baltimore, United States of America
Find articles by Bailey, J. in: JCI | PubMed | Google Scholar
Published February 11, 2021 - More info
Multiple studies have shown loss of SARS-CoV-2 specific antibodies over time after infection, raising concern that humoral immunity against the virus is not durable. If immunity wanes quickly, millions of people may be at risk for reinfection after recovery from COVID-19. However, memory B cells (MBC) could provide durable humoral immunity even if serum neutralizing antibody titers decline. We performed multi-dimensional flow cytometric analysis of S protein receptor binding domain (S-RBD)-specific MBC in cohorts of ambulatory COVID-19 patients with mild disease (n = 7), and hospitalized patients with moderate to severe disease (n = 7), at a median of 54 (39-104) days after symptom onset. We detected S-RBD-specific class-switched MBC in 13 of 14 participants, failing only in the individual with lowest plasma levels of anti-S-RBD IgG and neutralizing antibodies. Resting MBC (rMBC) made up the largest proportion of S-RBD-specific MBC in both cohorts. FCRL5, a marker of functional memory on rMBC, was more dramatically upregulated on S-RBD-specific rMBC after mild infection than after severe infection. These data indicate that most SARS-CoV-2-infected individuals develop S-RBD-specific, class-switched rMBC that resemble germinal center-derived B cells induced by effective vaccination against other pathogens, providing evidence for durable B cell-mediated immunity against SARS-CoV-2 after mild or severe disease.